Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page
Agenus and Zydus Lifesciences enter into a $141 million partnership to increase global accessibility of Botensilimab and Balstilimab treatments.

Agenus and Zydus Lifesciences enter into a $141 million partnership to increase global accessibility of Botensilimab and Balstilimab treatments.

by Team Small News | Jun 7, 2025 | Pharma, Zydus

Agenus Inc., a clinical-stage immuno-oncology company, has partnered with Zydus Lifesciences, a leading Indian pharmaceutical company, in a deal worth up to $141 million to expand access to two of its key pipeline assets, botensilimab and balstilimab. This...

Glenmark says the FDA may reinspect its Monroe site at any moment.

by Team Small News | Jun 6, 2025 | Glenmark, Pharma

Glenmark, an Indian pharmaceutical company, recently reported its earnings for the 2025 financial year. While the company’s overall performance was affected by a weak second half in its India business, it is planning to revive growth in both its core markets:...

Aurobindo gains FDA approval for generic version of Pfizer’s Chantix

by Team Small News | Jun 6, 2025 | Aurobindo Pharma, Pfizer, Pharma

The US Food and Drug Administration (FDA) has granted approval to Aurobindo Pharma for its varenicline tablets, available in 0.5 mg and 1 mg strengths. This approval marks a significant milestone for Aurobindo, as its varenicline tablets are the generic equivalent of...

Biocon to introduce its approved generic version of Liraglutide in the Indian market promptly.

by Team Small News | Jun 5, 2025 | Biocon, Pharma

Biocon, a leading biopharmaceutical company, has announced the launch of its first vertically integrated GLP-1 product in India, a generic version of liraglutide. The company believes that GLP-1s will be the key drivers of its future growth, and this launch marks a...

Sekhmet Pharma, owned by private equity, appoints ex-Lupin and Shilpa Medicare executive as its new chief executive officer.

by Team Small News | Jun 4, 2025 | Lupin, Pharma

A private equity consortium led by PAG, an Asia-focused investment firm, has announced the appointment of Santosh Kumar Mahil as the Managing Director and CEO of Sekhmet Pharmaventures Pvt Ltd. Mahil replaces Anil Khubchandani, who was appointed to the role in 2023....

Major pharmaceutical companies, including AstraZeneca, Pfizer, and Gilead, have made public their findings on new cancer treatments.

by Team Small News | Jun 4, 2025 | Pfizer, Pharma

The American Society of Clinical Oncology (ASCO) annual meeting was held in Chicago, featuring over 5,000 research abstracts on various cancer treatments and studies. Several pharmaceutical giants and biotech companies presented promising data, including AstraZeneca,...
« Older Entries
Next Entries »

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress